Keeping Institutional Fee Discussions Inside the Approval Process
Guide institutional sales teams through early fee questions without inventing commercial terms.
An institutional fee question often arrives before the salesperson has the information needed for a responsible answer. Asset size, vehicle, service scope, consultant involvement, and the firm’s approval process can all matter. Giving a rough number to keep momentum can create a commitment that the commercial team cannot support.
Treat the first question as discovery. Ask what the allocator is comparing, which mandate assumptions apply, and whether the request is for a screening range or a formal proposal. Clarify who will review commercial terms and what format the consultant or procurement team requires. The goal is to turn a casual question into a defined request.
At a first meeting, a staff member from a public plan asks, “Can you beat our current fee?” The salesperson replies, “I understand why cost is part of the review. To request an approved response, may I confirm the expected assets, vehicle, services, and whether there is a consultant template?” The staff member says the mandate is still being sized. The rep continues, “Then I should not imply a term today. I can document the assumptions that remain open and connect the appropriate commercial owner once your process defines them.”
That conversation protects credibility because it makes the next step useful. Managers can coach this by having reps practice declining a premature comparison while staying helpful. Review their notes for the missing assumptions, the commercial owner, and the date when a formal request becomes appropriate.
If the allocator supplies a competing number, record its stated scope without validating it or treating it as a comparable term. A responsible commercial comparison requires the same service assumptions, asset range, vehicle, and approval path for both sides.
Practice these next
A careful way for institutional sales teams to handle capacity questions using approved evidence.
Guide institutional sales teams through a careful conversation about a concentrated legacy holding.
Guide an insurer duration discussion toward documented assumptions and the right diligence owners.
Give institutional sales teams a disciplined way to describe process, risk, and evidence.
Teach institutional sales teams to map stakeholders without assuming influence.
Help institutional sales teams support a search led by a consultant while respecting the allocator's process.